Table 1 Comparison of clinical and laboratory test result among three groups.
N = 43 | Group A (n = 14) | Group B (n = 10) | Group C (n = 19) | F | p value |
|---|---|---|---|---|---|
Age | 46.2 ± 12.1 | 46.4 ± 13.5 | 42.2 ± 8.7 | 0.718 | 0.494 |
Course from start to transplantation | 33.4 ± 24.2 | 13.6 ± 9.3* | 10.8 ± 7.6* | 9.399 | 0.000 |
ALT AA (U/L) | 369.3 ± 413.1 | 923.7 ± 699.0 | 429.2 ± 709.3 | 2.684 | 0.081 |
ALT BLT (U/L) | 81.6 ± 66.4 | 754.5 ± 1084.7* | 120.6 ± 102.5# | 6.015 | 0.005 |
AST AA (U/L) | 252.2 ± 233.3 | 624.9 ± 563.2 | 465.4 ± 771.1 | 1.185 | 0.316 |
AST BLT (U/L) | 86.6 ± 32.4 | 278.5 ± 232.5* | 181.7 ± 222.1 | 3.129 | 0.055 |
TBIL AA (umol/L) | 422.9 ± 183.5 | 318.4 ± 135.1 | 328.7 ± 125.7 | 2.051 | 0.142 |
TBIL BLT (umol/L) | 563.5 ± 191.8 | 383.9 ± 157.6* | 438.3 ± 154.7* | 3.800 | 0.031 |
PTA% AA | 29.0 ± 10.8 | 26.9 ± 10.4 | 28.7 ± 10.2 | 0.129 | 0.879 |
PTA% BLT | 29.2 ± 13.1 | 21.6 ± 10.9 | 24.9 ± 9.9 | 1.382 | 0.263 |
CHE AA (U/L) | 3174.7 ± 1247.0 | 3527.5 ± 970.8 | 2967.8 ± 1171.4 | 0.769 | 0.470 |
CHE BLT (U/L) | 3140.0 ± 1584.8 | 3127.4 ± 1390.3 | 2705.7 ± 1082.5 | 0.549 | 0.582 |
ALB AA (g/L) | 31.0 ± 5.1 | 31.7 ± 4.3 | 29.8 ± 3.5 | 0.610 | 0.548 |
ALB BLT (g/L) | 32.4 ± 5.3 | 32.9 ± 3.2 | 30.0 ± 3.5 | 2.032 | 0.144 |
WBC AA (×109/L) | 6.7 ± 4.7 | 8.8 ± 3.5 | 5.0 ± 1.6# | 4.316 | 0.020 |
WBCBLT (×109/L) | 11.2 ± 4.5 | 9.4 ± 4.2 | 7.0 ± 8.7 | 1.616 | 0.211 |
WBCBLT/WBC AA | 2.3 ± 1.6 | 1.1 ± 0.6* | 1.4 ± 1.5 | 2.854 | 0.069 |
PLTAA (×109/L) | 83.9 ± 41.1 | 118.8 ± 53.6 | 79.6 ± 45.7 | 2.542 | 0.091 |
PLTBLT (×109/L) | 48.1 ± 20.8 | 109.8 ± 52.2* | 74.7 ± 38.0# | 7.910 | 0.001 |
PLTBLT/PLT AA | 0.7 ± 0.3 | 0.9 ± 0.2* | 1.0 ± 0.2* | 8.721 | 0.001 |
PLTAA/WBCAA | 16.1 ± 7.2 | 15.2 ± 8.5 | 16.4 ± 9.3 | 0.066 | 0.937 |
PLTBLT/WBCBLT | 4.6 ± 2.0 | 12.5 ± 4.9* | 14.9 ± 8.6* | 11.28 | 0.000 |
(WBCBLT/WBC AA)/(PLTBLT/PLT AA) | 3.9 ± 2.0 | 1.2 ± 0.6* | 1.5 ± 1.8* | 10.475 | 0.000 |